3 years, 2 promises, and still no progress: Panchkula's healthcare projects in limbo

1
2
3
Panchkula: In April 2022, then Haryana chief minister Manohar Lal Khattar stood before the public with a promise: two major healthcare projects would soon transform the medical landscape of Panchkula district.
Fast forward to 2025, and those promises remain unfulfilled, leaving residents frustrated and underserved.
The first project aimed to relocate the aging and overcrowded Kalka civil hospital to Tipra village. The second was the construction of a 25-bedded primary health centre (PHC) in Raytan village. But three years later, one project is tangled in bureaucratic red tape, while the other has been deemed unfeasible due to geographical challenges.
Kalka Hospital: A promise stuck in paperwork
The Kalka civil hospital, built in 1975, is bursting at the seams. Patients often wait in cramped corridors, and medical staff struggle to provide care in a space that has long outlived its capacity. The proposed relocation to Tipra village was supposed to change that.
Ten acres of land were identified by the municipal council in Pinjore, and a request was sent to expedite the transfer to the health department.
An estimated budget of Rs 18.23 crore was forwarded to the director general of health services. But since Feb 2025, the proposal has stalled at the government level. No further action has been taken.
Meanwhile, the hospital continues to operate in its outdated facility, and patients — especially those from economically weaker sections — are forced to travel to Panchkula or Chandigarh for treatment, often at great financial and physical cost.
Raytan PHC: A stream of problems
The second project, a PHC in Raytan, has faced a different kind of obstacle — nature itself. Of the three sites inspected, one in Chiken village was initially considered feasible. But during a site visit in April 2025, officials discovered a seasonal stream (choe) running through the middle of the land. The presence of a hume pipe culvert and the risk of heavy water flow during monsoons rendered the site unsuitable for construction.
Despite having two other sites to consider, no alternative has been finalized in three years. Residents argue that this delay reflects a lack of urgency and accountability.
Public outcry and political pressure
Vijay Bansal, president of Shivalik Vikas Manch and the RTI applicant who unearthed these details, didn't mince words. "Due to weak and ineffective political leadership in Kalka and the negligence of officials, a health centre has not been constructed for the semi-hilly regions like Kalka, Pinjore, and Morni," he said.
A senior Congress leader has also stepped in, writing to current CM Nayab Singh Saini, urging swift action on the pending projects. The letter highlights the dire consequences of delayed healthcare infrastructure — residents suffering from life-threatening conditions without access to proper treatment.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Time of India

an hour ago

• Time of India

ICMR's NIIH develops simple point of care test for haemophilia A, Von Willebrand Disease

A simple and affordable point-of-care test kit has been indigenously developed by the National Institute of Immunohaematology for early diagnosis of genetic bleeding disorders haemophilia A and Von Willebrand Disease . The test offers a promising alternative to the current standard of care which relies on complex and costly diagnostic procedures limited to very few tertiary facilities in India, Dr Rucha Patil, scientist at the National Institute of Immunohaematology ( NIIH ) in Mumbai, said. Bleeding disorders such as haemophilia A and Von Willebrand Disease (VWD) represent significant public health challenges in India due to underdiagnosis and limited access to diagnostic facilities. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Nunca use o saca-rolhas para abrir um vinho. O motivo vai te surpreender Blog Amo Vinhos Undo The point-of-care (PoC) test costs just Rs 582 while the current lab-based tests cost around Rs 2,086, Dr Bipin Kulkarni, scientist, at NIIH, said. The test kit was invented by former scientist Dr Shrimati Shetty and former ICMR postdoctoral fellow from NIIH Dr. Priyanka Kasatkar. Live Events The World Federation for Haemophilia has shown interest in procuring these tests for deployment in countries where the disease is prevalent, Dr Manisha Madkaikar, director of NIIH, Mumbai and Centre for Research Management and Control of Haemoglobinopathies (CRHCM) in Nagpur under the ICMR, said. "For India, this new rapid, visual card testing device has made testing possible even at primary health centres bringing diagnosis closer to the people who need it most. By using these PoC kits at PHCs and other local health centres, India can find and treat these bleeding disorders early, improve patient outcomes, and cut healthcare costs dramatically. This is a major step toward improving care for one of the country's most neglected health issues", Dr Madkaikar said. The Health Technology Assessment (HTA) analysis team of ICMR and Department of Health Research (DHR) recommended that the PoC kits for haemophilia A and VWD are suitable for primary facility-based screening and suggested integration of the test into the national health programs at primary healthcare level. This is currently being implemented in different states, Dr Kulkarni said. "This kit could help detect over 83,000 undiagnosed cases", he said, adding, "It would save the health system about Rs 42 crore, which is three times cheaper than the current method". Haemophilia A and VWD are the two most common inherited bleeding disorders. People with these conditions often suffer from joint swelling, easy bruising, muscle bleeding, and in women, heavy menstrual bleeding or complications during childbirth. "India is estimated to have 1.5 lakh people with haemophilia, but only about 27,000 are officially diagnosed," Dr Patil said. "Incidence of haemophilia A is 1 in 5,000 male births. VWD is known to affect 1 per cent of general population," she said. "Haemophilia A is passed down in families through the X chromosome (X linked recessive disorder)", Dr Patil explained. "Boys are usually the ones who have the disease, because they have only one X chromosome. If that X has the faulty gene, they don't have a 'backup' and will show symptoms. Girls usually have two X chromosomes, so if one X has the faulty gene, the other X can often make up for it. These girls are called 'carriers'," he said. "The VWD is an autosomal disease. This means both males and females can get it equally. It is not linked to gender like haemophilia," Dr Patil added.

Business Standard

2 hours ago

• Business Standard

Suven Life Sciences Ltd Slides 3.06%, BSE Healthcare index Shed 1.34%

Suven Life Sciences Ltd has added 6% over last one month compared to 0.02% fall in BSE Healthcare index and 0.02% drop in the SENSEX Suven Life Sciences Ltd fell 3.06% today to trade at Rs 220. The BSE Healthcare index is down 1.34% to quote at 42505.21. The index is down 0.02 % over last one month. Among the other constituents of the index, Syncom Formulations (India) Ltd decreased 2.97% and Concord Biotech Ltd lost 2.72% on the day. The BSE Healthcare index went up 15.59 % over last one year compared to the 5.82% surge in benchmark SENSEX. Suven Life Sciences Ltd has added 6% over last one month compared to 0.02% fall in BSE Healthcare index and 0.02% drop in the SENSEX. On the BSE, 155 shares were traded in the counter so far compared with average daily volumes of 1.08 lakh shares in the past one month. The stock hit a record high of Rs 272 on 12 Jun 2025. The stock hit a 52-week low of Rs 97.03 on 20 Jun 2024.

New Indian Express

6 hours ago

• New Indian Express

Super speciality GH for kids to come up in Guindy

CHENNAI: The state government has identified 6.5 acres of land at the King Institute of Preventive Medicine and Research in Guindy for setting up a super speciality hospital exclusively meant for children. The construction will begin in September and the work will be completed in two years, health minister Ma Subramanian said. Subramanian along with health secretary P Senthilkumar and Dr MGR Medical University vice-chancellor Dr K Narayanasamy inspected the site on Sunday. Speaking to reporters, Subramanian said the project will cost Rs 487.7 crore. The hospital will have a six-storey building and will include quarters for nurses, doctors, and professors, among other facilities. It will have 20 specialities and 750 beds, including 100 for ICU, he added. Apart from paediatric super speciality departments including medicine, critical care, surgery, and gastroenterology, it will also have higher paediatric super speciality departments including oncology, urology, neurosurgery, and transplant unit, the minister said. It will be constructed with biochemistry, microbiology, pathology and imaging suite diagnostic labs apart from dialysis unit, endoscopy suite, interventional radiology and other facilities. An announcement regarding an exclusive super speciality hospital for children had been made in the Assembly earlier.